Ceribell, Inc. (CBLL)
Nasdaq · Electromedical & Electrotherapeutic Apparatus · Manufacturing · CIK 1861107 · fiscal year ends in Dec
Closing price $27.84 on 29 Oct 2026; 52-week range $10.92 to $27.84.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $102.0M
- Revenue growth
- 31.7%
- Net income, last twelve months
- -$66.0M
- Earnings per share
- -$1.76
- Gross margin
- 88.9%
- Operating margin
- -68.6%
- Net margin
- -64.7%
- Free cash flow
- -$54.7M
- Return on equity
- -51.4%
- Market value
- $1.1B
- Cash
- $32.7M
- Debt
- $20.0M
- Debt to equity
- 0.16
- Shares outstanding
- 38.2M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $89.1M | -$58.4M | -$53.4M | -$1.46 | -$41.6M | 10-K filed 24 Feb 2026 |
| FY2024 | 31 Dec 2024 | $65.4M | -$39.7M | -$40.5M | -$3.39 | -$36.4M | 10-K filed 25 Feb 2025 |
| FY2023 | 31 Dec 2023 | $45.2M | -$30.0M | -$29.5M | -$5.56 | -$30.1M | 10-K filed 25 Feb 2025 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $28.1M | -$19.3M | -$0.51 |
| Q1 FY2026 | 31 Mar 2026 | $26.5M | -$19.7M | -$0.52 |
| Q4 FY2025 | 31 Dec 2025 | $24.8M | -$13.5M | -$0.36 |
| Q3 FY2025 | 30 Sep 2025 | $22.6M | -$13.5M | -$0.37 |
| Q2 FY2025 | 30 Jun 2025 | $21.2M | -$13.6M | -$0.38 |
| Q1 FY2025 | 31 Mar 2025 | $20.5M | -$12.8M | -$0.36 |
| Q4 FY2024 | 31 Dec 2024 | $18.5M | -$12.6M | -$0.40 |
| Q3 FY2024 | 30 Sep 2024 | $17.2M | -$10.4M | -$1.85 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By product, FY2025
| Segment | Revenue | Share |
|---|---|---|
| Product revenue | $67.3M | 75.6% |
| Subscription revenue | $21.7M | 24.4% |
Company events
The newest 8-K filings of 24 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 10 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 30 Jul 2026 | 8-K | Leadership change | 5.02 |
| 2 Jun 2026 | 8-K | Shareholder vote | 5.07 |
| 11 May 2026 | 8-K | Results | 2.02, 9.01 |
| 24 Feb 2026 | 8-K | Results | 2.02, 9.01 |
| 5 Jan 2026 | 8-K | Other events | 8.01, 9.01 |
| 2 Jan 2026 | 8-K | Leadership change | 5.02, 9.01 |
| 12 Dec 2025 | 8-K | Material agreement | 1.01, 9.01 |
| 9 Dec 2025 | 8-K | Other events | 8.01, 9.01 |
| 24 Nov 2025 | 8-K | Other events | 8.01, 9.01 |
| 4 Nov 2025 | 8-K | Results | 2.02, 9.01 |
| 24 Sep 2025 | 8-K | Material agreement | 1.01, 9.01 |
Every filing
The newest filings with the SEC of 68 held.
| Filed | Form | Period |
|---|---|---|
| 10 Aug 2026 | 10-Q | 30 Jun 2026 |
| 10 Aug 2026 | 8-K | 10 Aug 2026 |
| 30 Jul 2026 | 8-K | 28 Jul 2026 |
| 2 Jun 2026 | 8-K | 2 Jun 2026 |
| 11 May 2026 | 10-Q | 31 Mar 2026 |
| 11 May 2026 | 8-K | 11 May 2026 |
| 20 Apr 2026 | ARS | 31 Dec 2025 |
| 20 Apr 2026 | DEFA14A | – |
| 20 Apr 2026 | DEF 14A | 2 Jun 2026 |
| 24 Feb 2026 | S-8 | – |
| 24 Feb 2026 | 10-K | 31 Dec 2025 |
| 24 Feb 2026 | 8-K | 24 Feb 2026 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 1 Oct 2026 | Woo Raymond, Chief Technology Officer | Sale under a trading plan | 4,887 | $24.38 | $119.1K | 203,118 | 2 Oct 2026 |
| 15 Sep 2026 | Chao Xingjuan, President and CEO | Sale under a trading plan | 20,846 | $25.03 | $521.8K | 746,345 | 17 Sep 2026 |
| 15 Sep 2026 | Blumberg Scott, Chief Financial Officer | Sale under a trading plan | 846 | $25.00 | $21.1K | 146,600 | 17 Sep 2026 |
| 8 Sep 2026 | Foehr David, Senior VP, Finance and PAO | Sale under a trading plan | 1,755 | $24.26 | $42.6K | 34,144 | 10 Sep 2026 |
| 8 Sep 2026 | Foehr David, Senior VP, Finance and PAO | Sale under a trading plan | 7,500 | $24.25 | $181.9K | 34,144 | 10 Sep 2026 |
| 8 Sep 2026 | Woo Raymond, Chief Technology Officer | Sale under a trading plan | 4,887 | $24.33 | $118.9K | 203,118 | 10 Sep 2026 |
| 2 Sep 2026 | Chao Xingjuan, President and CEO | Sale under a trading plan | 39,540 | $24.61 | $973.1K | 767,191 | 4 Sep 2026 |
| 2 Sep 2026 | Blumberg Scott, Chief Financial Officer | Sale under a trading plan | 652 | $25.00 | $16.3K | 146,600 | 4 Sep 2026 |
| 24 Aug 2026 | Foehr David, Senior VP, Finance and PAO | Sale under a trading plan | 859 | $23.95 | $20.6K | 35,899 | 25 Aug 2026 |
| 21 Aug 2026 | Manni Joseph S., Chief Revenue Officer | Sale outside a trading plan | 1,361 | $24.02 | $32.7K | 55,956 | 25 Aug 2026 |
| 21 Aug 2026 | Foehr David, Senior VP, Finance and PAO | Sale under a trading plan | 993 | $24.02 | $23.9K | 36,758 | 25 Aug 2026 |
| 21 Aug 2026 | Woo Raymond, Chief Technology Officer | Sale outside a trading plan | 1,979 | $24.02 | $47.5K | 194,729 | 25 Aug 2026 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 1 Oct 2026 | Woo Raymond, Officer | 4,887 | $119.1K | 1 Oct 2026 |
| 15 Sep 2026 | Blumberg Scott, Officer | 846 | $21.2K | 15 Sep 2026 |
| 15 Sep 2026 | Chao Xingjuan, Officer, Director | 20,846 | $521.8K | 15 Sep 2026 |
| 8 Sep 2026 | Woo Raymond, Officer | 4,887 | $118.9K | 8 Sep 2026 |
| 8 Sep 2026 | Foehr David, Officer | 9,255 | $225.2K | 8 Sep 2026 |
| 2 Sep 2026 | Blumberg Scott, Officer | 652 | $16.3K | 2 Sep 2026 |
| 2 Sep 2026 | Chao Xingjuan, Officer, Director | 39,540 | $973.1K | 2 Sep 2026 |
| 24 Aug 2026 | Foehr David, Officer | 859 | $20.6K | 24 Aug 2026 |
| 21 Aug 2026 | Foehr David, Officer | 993 | $23.9K | 21 Aug 2026 |
| 21 Aug 2026 | Manni Joseph S., Officer | 1,361 | $32.7K | 21 Aug 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 14 Aug 2026 | TPG GP A, LLC | 13G amended | 7.8% | 3.0M |
| 6 Aug 2026 | FMR LLC | 13G amended | 15% | 5.7M |
| 27 Jul 2026 | BlackRock, Inc. | 13G | 5.03% | 1.9M |
| 14 May 2026 | The Global Value Investment Portfolio Management Pte Ltd | 13G amended | 4.2% | 1.6M |
| 12 May 2026 | Xingjuan Chao | 13G amended | 4.9% | 1.9M |
| 6 May 2026 | FMR LLC | 13G amended | 12.9% | 4.9M |
| 5 Feb 2026 | FMR LLC | 13G amended | 10.6% | 3.9M |
| 11 Dec 2025 | ABG WTT-Ceribell Limited | 13G amended | 4.6% | 1.7M |
| 5 Nov 2025 | FMR LLC | 13G amended | 12.2% | 4.5M |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 2.2M | +6.85% | 4.79 |
| 30 Sep 2026 | 2.0M | +10.94% | 5.04 |
| 15 Sep 2026 | 1.8M | -4.61% | 6.12 |
| 31 Aug 2026 | 1.9M | -9.31% | 5.58 |
| 14 Aug 2026 | 2.1M | +4.18% | 4.19 |
| 31 Jul 2026 | 2.0M | +9.24% | 5.46 |
| 15 Jul 2026 | 1.8M | -6.48% | 5.46 |
| 30 Jun 2026 | 2.0M | -1.81% | 4.39 |
Funds that hold it
From each fund's latest Form 13F.
135 funds held it at 30 Jun 2026: 70 added and 35 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| FMR LLC | 5,691,393 | $110.7M | +840,962 |
| TPG GP A, LLC | 3,761,154 | $73.2M | -206,268 |
| Red Tree Management, LLC | 2,205,661 | $42.9M | 0 |
| BlackRock, Inc. | 1,936,093 | $37.7M | +122,938 |
| Vanguard Capital Management LLC | 1,130,346 | $22.0M | -6,786 |
| KCM Capital Inc | 1,125,000 | $21.9M | -275,000 |
| Federated Hermes, Inc. | 939,600 | $18.3M | +136 |
| Franklin Resources Inc. | 918,349 | $17.9M | +108,835 |
| Adage Capital Partners GP, L.l.c. | 900,000 | $17.5M | +143,249 |
| Bank of New York Mellon Corp | 896,488 | $17.4M | -264,279 |
Peers
Companies in the same industry.
- Medtronic plc (MDT): revenue $37.5B, market value $124.3B
- LivaNova plc (LIVN): revenue $1.5B, market value $4.5B
- Integer Holdings Corp. (ITGR): revenue $1.8B, market value $4.3B
- Axogen, Inc. (AXGN): revenue $266.9M, market value $3.0B
- TransMedics Group, Inc. (TMDX): revenue $668.5M, market value $2.3B
- Conmed Corp. (CNMD): revenue $1.4B, market value $1.4B